Advanced Therapy Medicinal Products

An EMA workshop in London gave an important insight into the implementation of the European regulation on Advanced Therapy Medicinal Products (ATMPs).

Valérie Pimpaneau, Vice President CMC & Quality

Valerie Pimpaneau is responsible for the management of projects involving the development of CMC, bio-analytical and quality strategies for Drugs, Biologics, Gene and Cell Therapy. Her experience in the Biopharmaceutical industry allows Valerie to interface efficiently with the technical and regulatory teams and help coordinate CMC activities in line with the product development phases.

Download the full Publication now